
Cognex Q2 Earnings Call Centers on AI and Data Center Growth
CGNX is leaning on AI-enabled machine vision, data center demand and customer expansion as margins improve and 2026 growth broadens.
Follow the latest financial and economic news, market updates, reports, and analysis on PipVero.

CGNX is leaning on AI-enabled machine vision, data center demand and customer expansion as margins improve and 2026 growth broadens.

Resmed's Q4 earnings and revenues beat estimates, but shares fall as fiscal 2027 revenue guidance trails the consensus mark.

For the second quarter ending June 28, Sweetgreen's same-store sales fell 6.2% – its sixth straight decline.

Imperial Oil's stronger Q2 earnings contrast with lower 2026 refinery targets, putting the focus on a second-half volume recovery.

SPCX's 24.5% monthly slide contrasts with surging revenues, profitable Starlink growth and fast AI gains, while valuation and spending keep risks high.

SPCX's $6.7B cloud deal boosts near-term AI revenue visibility, but heavy capex, concentration and reported AI losses keep economics mixed.

Super Micro Computer heads into Q4 fiscal 2026 earnings with AI infrastructure demand, delayed deployment conversions and margin pressure in focus.

SGI's Q2 margins and cash flow improve on synergy gains, but weaker sales and a lower 2026 earnings outlook temper the results.

New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cerebras Systems Inc. ("Cerebras" or the "Company") (NASDAQ: CBRS). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Cerebras investor and have suffered losses, or if you have information that could assist in the Cerebras investigation, you may CLICK HERE to contact us.

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against EquipmentShare.Com Inc (“EquipmentShare” or the “Company”) (NASDAQ: EQPT) on behalf of investors who purchased or otherwise acquired EquipmentShare common stock pursuant and/or traceable to the Company's initial public offering on or around January 23, 2026 (the “IPO”), or between January 23, 2026 and June 23, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in EquipmentShare and have suffered losses, you may CLICK HERE to contact us.

MRNA keeps its 2026 growth target intact while cutting cost guidance and advancing flu, oncology and rare-disease programs toward key milestones.

Cincinnati Financial's disciplined underwriting, agency-led growth and rising investment income support long-term growth despite catastrophe risks.

Space stocks are rallying across the board in midday Friday trading, with SpaceX (NASDAQ:SPCX | SPCX Price Prediction) shares leading the group.

AMD slides after beating Q2 estimates, but strong AI and data center growth outlooks may steer investors toward ETFs with meaningful exposure to this chipmaker.

Abbott broadens Diagnostics growth with Exact Sciences, as Cancer Diagnostics gains and resilient routine testing offset respiratory weakness.